Hester Biosciences Limited
HESTERBIO
Rank in Stocks
#16461
Hester Biosciences Limited, founded in 1987 and headquartered in Ahmedabad,... Hester Biosciences Limited, founded in 1987 and headquartered in Ahmedabad, India, specializes in the production and commercialization of veterinary vaccines and a comprehensive array of animal health solutions. The company's operations span both domestic and international markets, structured around two primary divisions: Poultry Healthcare and Animal Healthcare. Its extensive range of poultry vaccines targets numerous conditions, including Newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reovirus infections, Marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, and avian encephalomyelitis. For larger animals, Hester Biosciences provides vaccines designed to combat ailments such as Goat Pox, Peste des Petits Ruminants (PPR), Brucellosis, Mastitis, Metritis, various infectious diseases, reproductive disorders, theileriosis, and parasitic infestations. Beyond vaccines, the company's product portfolio encompasses vital feed supplements like toxin binders, trace minerals, enzyme preparations, and bypass fats. It also supplies disinfectants for maintaining farm hygiene and sanitizing equipment, along with water purification solutions. Nutritional support products are offered, including mineral mixtures, fertility boosters, and growth tonics. A significant portion of their offerings consists of herbal preparations, featuring growth promoters, natural alternatives to choline chloride, stress and immunity enhancers, respiratory aids, liver tonics, wound healing agents, uterine and digestive tonics, anti-bloat remedies, ectoparasiticides, and treatments for anti-mastitis and anti-prolapse conditions.
Share Price
$24.58
Last synced: 2026-11-09
Market Cap
$209.07M
Change (1 day)
-2.10%
Change (1 year)
29.33%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Hester Biosciences Limited (HESTERBIO)
Category
Healthcare
Operating Margin for Hester Biosciences Limited (HESTERBIO)
Operating Margin as of November 2026 TTM: 19.92%
According to Hester Biosciences Limited's latest financial reports, its current operating margin (TTM) is 19.92%. At the end of 2025 the company had an operating margin of 14.63%.
Operating Margin history for Hester Biosciences Limited from 2006 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 19.92% | 36.16% |
| 2025 | 14.63% | 22.12% |
| 2024 | 11.98% | 2.74% |
| 2023 | 11.66% | -78.12% |
| 2022 | 53.29% | 101.17% |
| 2021 | 26.49% | 3.60% |
| 2020 | 25.57% | -27.23% |
| 2019 | 35.14% | 20.71% |
| 2018 | 29.11% | 16.39% |
| 2017 | 25.01% | 3.69% |
| 2016 | 24.12% | 28.71% |
| 2015 | 18.74% | -3.05% |
| 2014 | 19.33% | -12.65% |
| 2013 | 22.13% | -27.47% |
| 2012 | 30.51% | -6.61% |
| 2011 | 32.67% | 2.51% |
| 2010 | 31.87% | -12.92% |
| 2009 | 36.60% | -11.96% |
| 2008 | 41.57% | 3.95% |
| 2007 | 39.99% | -5.62% |
| 2006 | 42.37% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -99.03% |
DE
|
|
| 19.68% | -99.01% |
DE
|
|
| 13.26% | -99.33% |
JP
|
|
| 17.08% | -99.14% |
CH
|
|
| 14.92% | -99.25% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Hester Biosciences Limited's operating margin
What is Hester Biosciences Limited's operating margin?
Hester Biosciences Limited's operating margin is 19.92%, as of Nov 2026.
What was Hester Biosciences Limited's operating margin in 2025?
In 2025, Hester Biosciences Limited's operating margin was 14.63%, compared with 11.98% in 2024.
How has Hester Biosciences Limited's operating margin changed since 2020?
From 2020 to 2025, Hester Biosciences Limited's operating margin was highest in 2022 (53.29%) and lowest in 2023 (11.66%).
How does Hester Biosciences Limited's operating margin compare with similar companies?
Hester Biosciences Limited's operating margin (19.92%) is higher than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.